In the spirit of closing out one year and looking forward to the next, contributors to this issue ask readers to consider how they can go about “Clearing the Path to Tomorrow’s Impactful Trials” through improved understanding of timely aspects of informed consent, patient recruitment and engagement, trial design, artificial intelligence, and more.